Hexagon Bio's Series A Round

Hexagon Bio raised a round of funding on July 20, 2017. Investors include 8VC.

Hexagon Bio is mining massive amounts of genomic data from fungal genomes to identify novel drugs for diseases with unmet needs. Its expertise is in genomics, synthetic biology, chemistry and computat…

Articles about Hexagon Bio's Series A Round: